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Aims: To examine the association between polymorphisms of the ciliary neurotrophic 
factor gene (CNTF) and total and central adiposity markers in European adolescents. 
Methods: This cross-sectional study involved 1057 European adolescents aged 12-18 
years, all enrolled in the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-
Sectional Study. Five polymorphisms of CNTF were genotyped and the weight, height, 
waist and hip circumference, and triceps and subscapular skinfold thickness of the 
subjects determined.  
Results: The T allele of rs2509914, the C allele of rs2515363, and the G allele of 
rs2515362, were significantly associated (after Bonferroni correction) with higher values 
for several adiposity markers under different inheritance models. The CNTF CCGGA 
haplotype (rs2509914, rs17489568, rs2515363 rs1800169 and rs2515362) was also 
significantly associated with lower BMI, waist circumference, waist/height and waist/hip 
ratio values compare to the TCCGG haplotype under several inheritance models. 
Conclusions: Three polymorphisms - rs2509914, rs2515363 and rs2515362 - and the 
CCGGA haplotype of CNTF were significantly associated with adiposity in European 
adolescents. These results suggest the potential role of genetics, and CTNF in particular, 
in the development of obesity-related phenotypes. 
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Introduction 
Obesity is a worldwide health problem, particularly in young people(1). The obese 
phenotype probably occurs as a result of complex interactions between an individual’s 
genetic background, and environmental, behavioural and socioeconomic factors. In 
simple terms, however, it is the result of a chronic excess of energy intake over energy 
expenditure. Key factors that regulate energy intake include satiety, while energy 
expenditure is influenced by basal metabolism, physical activity, thermoregulation and 
digestive processes(2,3).  
Many genes have been related to obesity, but those involved in the regulation of 
the appetite centre in the brain are especially important. In monogenetic obesity(4), 
hormones and other molecules such as leptin (LEP), leptin receptor (LEPR), pro-
opiomelacortin (POMC) and prohormone convertase 1 (PCSK1) play important roles. 
However, polygenic obesity, the most common form, involves many more complex 
interactions between multiple genes and factors.   
Neurotrophic factors help in the control and development of synaptic function and 
plasticity(5). These factors can also control body weight, and mutations of brain-derived 
neurotrophic factor (BDNF) and BDNF receptor (TrkB) have been associated with severe 
obesity in humans(6,7). Ciliary neurotrophic factor (CNTF) is a neurocytokine belonging 
to the interleukin 6 family mainly involved in response to injury to the nervous system 
(brain lesions lead to a significant increase in CNTF mRNA and CTNF in the 
hypothalamus)(2). However, it has also been related to the control of body weight. In a 
placebo-controlled trial, the subcutaneous administration of recombinant CNTF to people 
with obesity led to a reduction in food intake and subsequent weight loss via the 
promotion of satiety(8). The mechanisms underlying the satiety-improving role of CNTF 
seem to be related to similarities between the signalling cascades of leptin and CNTF, 
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which overlap both in receptors and mediators. Leptin inhibits orexigenic hormones such 
as neuropeptide Y (NPY) and agouti-related peptide (AgRP), which increase food intake, 
and stimulates anorexigenic factors such as α-melanocyte stimulating hormone (αMSH), 
which inhibits food intake(9). This raises the possibility that CNTF acts on leptin-
responsive neurons to regulate satiety and body weight(2).  However, while it has been 
reported that CNTF may reduce body weight and improve insulin action in both rodents 
and humans,(10) the evidence is poor (especially in humans) that endogenous CNTF 
signalling is involved in the control of energy balance, certainly in obesity and 
hyperphagia(11,12). Indeed, some studies have found an association between CNTF 
signalling and BMI and body weight(13), but others have not(14–16). 
Data obtained in the Healthy Lifestyle in Europe by Nutrition in Adolescence 
(HELENA) study provide a means of studying the association between CNTF 
polymorphisms and adiposity makers in European adolescents. The HELENA study was 
designed to provide reliable data on nutrition and health-related variables in a relatively 
large sample of European adolescents from nine countries (Greece, Germany, Belgium, 
France, Hungary, Italy, Sweden, Austria and Spain), and includes information on 5 
polymorphisms of the CNTF gene as well as markers of adiposity. To our knowledge, 
CNTF polymorphisms have not previously been identified in genome-wide association 
studies of body weight or body composition in people of any age.  
 The aim of the present study was to examine the association of CNTF 
polymorphisms with total and central adiposity markers in European adolescents.  
 
Material and Methods 
Study subjects 
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This cross-sectional study involved 1057 adolescents aged 12-18 years - all enrolled in 
the HELENA study, which was undertaken in 2006-2007 - for whom data on CNTF 
polymorphisms (rs2509914, rs17489568, rs2515363, rs1800169 and rs2515362) and 
adiposity markers are available. After receiving complete information about the aims and 
methods of the HELENA study, the study subjects and their parents or guardians provided 
written consent to be involved. All data examined in the present work were collected from 
subjects who met the general HELENA study inclusion criteria(17). The study was 
performed following the guidelines of the Declaration of Helsinki 1964 (revision of 
Edinburgh 2000) and Good Clinical Practice, and adhering to the legislation regarding 
clinical research in humans in each of the participating countries. The protocol was 
approved by the local human research review committees of the centres involved (18).  
 
Assessment of adiposity 
Weight and height were measured following standard methods(17). Waist and hip 
circumferences were measured in triplicate using a Seca 200 inelastic anthropometric tape 
(Seca Deutschland, Hamburg, Germany), and used as surrogate measures of central body 
fat. Waist/height and waist/hip ratios were then calculated. Body mass index (BMI) was 
calculated as weight in kg/(height in m)2, and the subjects classified as being of normal 
weight, overweight, or obese according to Cole et al(19). Skinfold thicknesses were 
measured to the nearest 0.2 mm in triplicate on the left side biceps, triceps, subscapularis, 
suprailium, thigh, and medial calf, using a Holtain caliper (Holtain Ltd, Crymych, UK).  
Percentage body fat was calculated from the triceps and subscapular skinfold thickness 
data using the equations of Slaughter et al (20). Finally, the fat mass index (FMI) was 




Blood samples were genotyped using an Illumina System (Illumina Inc., San Diego, CA, 
USA) and analysed using GoldenGate software (GoldenGate Inc., San Francisco, CA, 
USA). The genotyping rate was ≥99.9% and all polymorphisms were in Hardy-Weinberg 
equilibrium (HWE) (P>0.19 in all cases; Table 1; online). All CNTF polymorphisms were 
in linkage disequilibrium (LD) (Figure 1; online).  
 
Statistical analysis 
Deviations from Hardy-Weinberg equilibrium (HWE) were determined by means of an 
exact test considering a p value of 0.05 as a threshold. Associations between 
polymorphisms and adiposity markers were assessed via linear regression models. Five 
inheritance models (dominant, recessive, log-additive, codominant and overdominant) 
were contemplated in all analyses. The adjustment variables were age, sex and centre. 
The influence of each polymorphism on the phenotypic variables measured was examined 
using the likelihood ratio test (LRT), employing a model contemplating the 
polymorphism and a null model without it. Analyses were performed using the SNPassoc 
R package(21). We considered the associations between all single nucleotide 
polymorphisms (SNPs) and each phenotype under a given inheritance model as the family 
test, i.e., the number of tests was equal to the number of SNPs analysed. Therefore, a 
corrected P value for multiple comparison following the Bonferroni method would be 
0.01 (0.05/5). Significant associations were selected to perform further haplotype 
analysis, i.e. only SNPs and phenotypes significant associated were considered for next 
analyses. Given these associations were used in further analyses and the linkage 
disequilibrium existent between gene polymorphisms (see below), which reduces the 
number of independent tests, we performed a exploratory selection of associations using 
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a method to control the expected proportion of false positives (False Discovery Rate 
[FDR])(22,23) instead the Bonferroni correction, which is more stringent(24). Therefore, 
associations with an FDR of <0.1 were used in haplotype analyses.   
LD between polymorphisms and haplotype block structures were assessed using 
Haploview 4.2 (http://www.broad.mit.edu/mpg/haploview) and haplo.stats R 
package(25). First, haplotype blocks were generated by the four-gamete rule 
algorithm(26). For each block, we tested whether the observed frequencies of haplotypes 
were deviated from those expected under linkage equilibrium. Finally, the association 
between haplotypes and phenotypes was assessed using a permutation procedure. Only 
the additive and dominant models were contemplated given the low frequency of some 
haplotypes. For significant associations, regression analyses were performed between 
haplotypes and phenotypes with the purpose of testing significant differences between 
haplotype levels. Given the low number of comparisons (only four haplotypes, 
disregarding those with very low frequencies), the P values were not corrected for 
comparisons between haplotype levels. 
 
Results 
Table 2 shows the anthropometric characteristics of the study sample. 
 
Association between CNTF polymorphisms and adiposity markers 
Three (rs2509914, rs2515363 and rs2515362) of the five analysed SNPs showed 
significant associations with adiposity markers after Bonferroni correction (Figures 
2,3,4).  Significant associations after less stringent correction (FDR<0.05) are shown in 
the supplementary appendix (Figures 1-6), along with the P values for all associations 
(Figures 7-14). 
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 An association was seen between the minor T allele of the rs2509914 
polymorphism and increased BMI under the recessive inheritance model (P=0.003), with 
a larger waist circumference under the codominant, recessive and additive models 
(P=0.00107, P=0.00034 and P=0.00071, respectively), with a higher waist/height ratio 
under the codominant, recessive and additive models (P=0.00013, P=5e-05 and P=8e-05, 
respectively), and with a higher waist/hip ratio the under dominant, codominant, recessive 
and additive models (P=0.00305, P=0.00262, P=0.00736 and P=0.00056 respectively) 
(Figure 2). 
 We also observed an association between the minor C allele of the rs2515363 
polymorphism and higher BMI under the codominant and recessive models (P=0.00841 
and P=0.00204 respectively), with a higher waist circumference under the codominant, 
recessive and additive models (P=0.00082, P=0.00023 and P=0.00065 respectively), with 
a higher waist/height ratio under the codominant, recessive and additive models 
(P=0.00012, P=4e-05 and P=8e-05, respectively), and with a higher waist/hip ratio under 
the dominant, codominant, recessive and additive models (P=0.0035, P=0.00303, 
P=0.00775 and P=0.00066 respectively) (Figure 3). 
Finally, an association was seen between the minor G allele of the rs2515362 
polymorphism and a higher BMI under the codominant and recessive models (P=0.00781 
and P=0.00188, respectively), with a higher waist circumference under the codominant, 
recessive and additive models (P=0.00087, P=0.00027 and P=0.00059 respectively), with 
a higher waist/height ratio under the codominant, recessive and additive models 
(P=0.00011, P=4e-05 and P=7e-05, respectively), with a higher hip circumference under 
the recessive model (P=0.00961), and with a higher waist/hip ratio under the dominant, 




Association between CNTF polymorphism haplotypes and adiposity markers 
The CNTF block contained the rs2509914, rs17489568, rs2515363 rs1800169 and 
rs2515362 polymorphisms (Figure 1; online). The CNTF CCGGA haplotype was 
significantly associated with a lower BMI (under the dominant inheritance model, global: 
P=0.0098, difference between groups 0.04, 95%CI =0.01-0.06, P=0.0019; under the 
additive inheritance model, global P=0.04555, difference between haplotype groups 0.02 
kg/m² 95%CI=0.00-0.03, P=0.018; differences between groups obtained from models 
using a response variable log transformed), with lower waist circumference (under the 
dominant inheritance model, global P=0.0049, difference between haplotype groups 0.02, 
95%CI=0.01-0.03, P=0.004; under the additive model, global P=0.00925, difference 
between haplotype groups 0.02 cm; 95%CI=0.01-0.03, P=0.0003), with lower 
waist/height ratio (under the dominant inheritance model, global P=7e-04, difference 
between halplotype groups 0.02, 95%CI =0.01-0.03, P=0.0012; under the additive model, 
global P=0.002, difference between haplotype groups 0.02; 95%CI=0.01-0.03, P=0.0001) 
and with a lower waist/hip ratio (under the dominant model, global P=0.01305, difference 
between haplotype groups 0.01, 95%CI=0.01-0.02, P=0.0005; under the additive model, 




The present results reveal a solid association between the rs2509914, rs2515363 and 
rs2515362 CNTF polymorphisms and the adiposity markers BMI, waist circumference, 
waist/height ration and waist/hip ratio in European adolescents. An association was also 
seen between the CNTF CCGGA haplotype (rs2509914, rs17489568, rs2515363, 
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rs1800169 and rs2515362) and BMI, waist circumference, and the waist/hip ratio and 
waist/height ratios. Taken together, these findings suggest a role for CNTF in body weight 
regulation in adolescents.  
To our knowledge, only one study has examined the association between CNTF 
polymorphisms and adiposity markers in humans. Heidema et al.(27) followed a cohort 
of stable weight and weight-gaining Dutch adults (N=545), and found a significant 
association between the A allele of rs1800169 and weight gain (odds ratio=2.15, 95%CI: 
1.27–3.64, P=0.004) in women. These findings partially concur with the present results, 
which showed an association of the G allele of rs1800169 with reduced adiposity marker 
values. However, this association was observed for both females and males. It may be 
that the mentioned CNTF polymorphisms and haplotype are associated with the altered 
expression of CNTF proteins, predisposing their possessors to weight gain. CNTF plays 
a role in the regulation of body weight(2), and high levels of CNTF due to a neuronal 
injury-induced inflammatory response and fever(28) leads to weight loss.  The 
administration of recombinant CNTF(8) causes the same. Such weight loss is more likely 
to occur through satiety mechanisms given the similarity between the CNTF and leptin 
signalling cascades: there is a close relationship between the leptin receptor and the CNTF 
receptor complex, an overlap between CNTF and leptin activator molecules (e.g., STAT3) 
and CNTF and leptin receptors have overlapping distributions in some hypothalamic 
nuclei involved in feeding control(2). These similarities might explain the underlying 
mechanism through which these CNTF polymorphisms lead to functionally altered CNTF 
proteins and therefore effect satiety and weight control.  
The present results should be taken with caution given the cross-sectional nature 
of the study and potential variability in the ethnic make-up of the study sample, which 
was unknown.  
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In conclusion, an association was seen between the rs2509914, rs2515363 and 
rs2515362 polymorphisms of CNTF and adiposity markers in adolescents from nine 
European countries. We also observed an association between a CNTF haplotype 
(rs2509914, rs17489568, rs2515363, rs1800169 and rs2515362) and several adiposity 
markers. These findings suggest that CNTF may play an important role in predisposition 
to the appearance of overweight/obesity in adolescents. 
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